Abstract
MgO–Bi2−xCrxO3 nanocomposites for x = 0 and 0.07 were fabricated using the solvent-deficient route. X-ray diffraction method, scanning electron microscopy (SEM), energy dispersive X-ray analysis (EDXA) and UV–Vis spectroscopy were employed to study the properties. The samples were also evaluated for the antibacterial activity. The x = 0 sample showed a dominant monoclinic crystalline structure of alphatext{-}{text{Bi}}_{2}{text{O}}_{3} phase. No peaks attributed to MgO were observed. Cr-doped text{MgO}{-}{text{Bi}}_{2}{text{O}}_{3} in which Bi was substituted showed that {text{the tetragonal BiCrO}}_{3} phase was also present in the text{MgO}{-}{text{Bi}}_{2}{text{O}}_{3} composite. The Scherrer formula was employed to determine the crystallite size of the samples. The Cr-doped sample showed a decrease in the crystallite size. The microstructures of the non-doped MgO–Bi2O3 and MgO–Bi1.93Cr0.07O3 composites consisted of micrometer sized grains and were uniformly distributed. Direct transition energy gap, {E}_{text{g}} decreased from 3.14 to 2.77 eV with Cr-doping as determined from UV–Vis spectroscopy. The Cr-doped text{MgO}{-}{text{Bi}}_{2}{text{O}}_{3} nanocomposites exhibited two energy gaps at 2.36 and 2.76 eV. The antibacterial activity was determined against gram-negative bacteria (Salmonella typhimurium and Pseudomonas aeruginosa) and gram-positive bacteria (Staphylococcus aureus) by disc diffusion method. Cr-doping led to a decrease in inhibitory activity of MgO–Bi2−xCrxO3 nanocomposite against the various types of bacteria.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have